AR133755A1 - KRAS G12D MODULATION COMPOUNDS - Google Patents
KRAS G12D MODULATION COMPOUNDSInfo
- Publication number
- AR133755A1 AR133755A1 ARP240102388A ARP240102388A AR133755A1 AR 133755 A1 AR133755 A1 AR 133755A1 AR P240102388 A ARP240102388 A AR P240102388A AR P240102388 A ARP240102388 A AR P240102388A AR 133755 A1 AR133755 A1 AR 133755A1
- Authority
- AR
- Argentina
- Prior art keywords
- kras
- compound
- modulation compounds
- pharmaceutically acceptable
- modulation
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de la fórmula (J). Una composición farmacéutica que comprende un compuesto de una cualquiera de las reivindicaciones 1 a 75, y un excipiente farmacéuticamente aceptable. Un método para elaborar un medicamento para inhibir la metástasis de cáncer en un sujeto que lo necesita, caracterizado porque se usa un compuesto de una cualquiera de las reivindicaciones 1 a 75, o una sal farmacéuticamente aceptable de este.A compound of formula (J). A pharmaceutical composition comprising a compound of any one of claims 1 to 75, and a pharmaceutically acceptable excipient. A method for preparing a medicament for inhibiting cancer metastasis in a subject in need thereof, characterized in that a compound of any one of claims 1 to 75, or a pharmaceutically acceptable salt thereof, is used.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063562155P | 2020-03-06 | 2020-03-06 | |
| US202063640100P | 2020-04-29 | 2020-04-29 | |
| US202363581551P | 2023-09-08 | 2023-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR133755A1 true AR133755A1 (en) | 2025-10-29 |
Family
ID=97521978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240102388A AR133755A1 (en) | 2020-03-06 | 2024-09-06 | KRAS G12D MODULATION COMPOUNDS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR133755A1 (en) |
-
2024
- 2024-09-06 AR ARP240102388A patent/AR133755A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022012714A (en) | INHIBITORS OF THE REPLICATION OF NOROVIRUS AND CORONAVIRUS. | |
| AR132007A1 (en) | COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K | |
| UY39529A (en) | NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE | |
| CO2024001367A2 (en) | Antiviral compounds | |
| AR132338A1 (en) | RAS INHIBITORS | |
| CL2021003202A1 (en) | Pyrrolidine compounds | |
| AR133988A1 (en) | RAS-PI3K INHIBITORS AND THEIR USES | |
| AR134265A1 (en) | HETEROCYCLES AND THEIR USES | |
| CO2021014210A2 (en) | Pyrrole compounds | |
| AR127247A1 (en) | CYCLOPENTYLPYRAZOLE CDK2 INHIBITORS | |
| ECSP22032016A (en) | IRAQ INHIBITOR AND METHOD OF PREPARATION THEREOF AND USE THEREOF | |
| CO2021017202A2 (en) | tricyclic compounds | |
| AR074309A1 (en) | ANTI-INFLAMMATORY COMPOUNDS AND THEIR PHARMACEUTICAL, DENTIFRICAL AND ADHESIVE COMPOSITIONS. METHOD | |
| CO2026000093A2 (en) | Pharmaceutical compositions for nek7 kinase inhibitors | |
| AR127496A1 (en) | CD73 COMPOUNDS | |
| AR133755A1 (en) | KRAS G12D MODULATION COMPOUNDS | |
| MX2022005199A (en) | SSAO INHIBITORS AND USE THEREOF. | |
| AR133133A1 (en) | COMPOUNDS THAT MODULATE KRAS | |
| AR132408A1 (en) | COMPOUNDS THAT MODULATE KRAS | |
| AR133135A1 (en) | COMPOUNDS THAT MODULATE KRAS | |
| MX2024004551A (en) | Inhibitors of human immunodeficiency virus replication. | |
| AR105400A1 (en) | JAK1 INHIBITORS | |
| AR128894A1 (en) | KRAS INHIBITORS | |
| AR134197A1 (en) | COMPOUNDS FOR THE TREATMENT OF KIDNEY DISEASE | |
| AR129171A1 (en) | HETEROAROMATIC COMPOUNDS |